Blue nails and acquired immunodeficiency syndrome: not always associated with azidothymidine use.
Nail dyschromia in patients infected with human immunodeficiency virus (HIV) was first described in 1987 by Furth and Kazakis. It has since been reported in many patients with the acquired immunodeficiency syndrome (AIDS), predominantly in those taking azidothymidine. There have been only three reports of nail pigmentation in HIV-infected patients who had not received azidothymidine. We describe such a case.
Glaser
D A
DA
Division of Dermatology, Saint Louis University School of Medicine, Missouri, USA.
Remlinger
K
K
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications*; D000328:Adult; D000998:Antiviral Agents / Q000009:adverse effects; D006801:Humans; D008297:Male; D009260:Nail Diseases / Q000209:etiology*; D010859:Pigmentation Disorders / Q000209:etiology*; D015215:Zidovudine / Q000009:adverse effects
D000998:Antiviral Agents; D015215:Zidovudine